Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8865 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD2533 |
Approved |
0.8503 |
High Similarity |
NPD2532 |
Approved |
0.8503 |
High Similarity |
NPD2534 |
Approved |
0.831 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8188 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8141 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8138 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8065 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8027 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8027 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7986 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7973 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7962 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7961 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7949 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7898 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7891 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7877 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7875 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7871 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7867 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.784 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7826 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7794 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7792 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7791 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7748 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7725 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7722 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7718 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7718 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7716 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7712 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7697 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7625 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD943 |
Approved |
0.7603 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD7054 |
Approved |
0.759 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7582 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7578 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7572 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7545 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7535 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD919 |
Approved |
0.753 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7452 |
Intermediate Similarity |
NPD920 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7442 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7413 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7403 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.74 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7391 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7365 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7358 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7353 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7338 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7325 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD5494 |
Approved |
0.726 |
Intermediate Similarity |
NPD1203 |
Approved |
0.726 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7248 |
Intermediate Similarity |
NPD411 |
Approved |
0.7229 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7222 |
Intermediate Similarity |
NPD37 |
Approved |
0.7222 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7206 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7206 |
Intermediate Similarity |
NPD74 |
Approved |
0.7195 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7195 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7195 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7193 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7132 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7132 |
Intermediate Similarity |
NPD9267 |
Approved |
0.712 |
Intermediate Similarity |
NPD8319 |
Approved |
0.712 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7114 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7041 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7037 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD6776 |
Approved |
0.6995 |
Remote Similarity |
NPD6778 |
Approved |
0.6995 |
Remote Similarity |
NPD6779 |
Approved |
0.6995 |
Remote Similarity |
NPD6780 |
Approved |
0.6995 |
Remote Similarity |
NPD6777 |
Approved |
0.6995 |
Remote Similarity |
NPD6782 |
Approved |
0.6995 |
Remote Similarity |
NPD6781 |
Approved |
0.6993 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6987 |
Remote Similarity |
NPD2344 |
Approved |
0.6982 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD7236 |
Approved |
0.6978 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6971 |
Remote Similarity |
NPD8313 |
Approved |
0.6971 |
Remote Similarity |
NPD8312 |
Approved |
0.6968 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6966 |
Remote Similarity |
NPD4626 |
Approved |
0.6966 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD1778 |
Approved |
0.6949 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6931 |
Remote Similarity |
NPD7874 |
Approved |
0.6931 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD5353 |
Approved |
0.6919 |
Remote Similarity |
NPD7228 |
Approved |
0.6908 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6908 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6908 |
Remote Similarity |
NPD3268 |
Approved |
0.6901 |
Remote Similarity |
NPD2403 |
Approved |
0.6901 |
Remote Similarity |
NPD9281 |
Approved |
0.6899 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD5691 |
Approved |
0.6894 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6883 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD7697 |
Approved |
0.6882 |
Remote Similarity |
NPD7698 |
Approved |
0.6882 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD1653 |
Approved |
0.6867 |
Remote Similarity |
NPD2798 |
Approved |
0.6863 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6863 |
Remote Similarity |
NPD520 |
Approved |
0.6852 |
Remote Similarity |
NPD6273 |
Approved |
0.6849 |
Remote Similarity |
NPD17 |
Approved |
0.6846 |
Remote Similarity |
NPD1283 |
Approved |
0.6845 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6842 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6838
|
Remote Similarity |
NPD9261 |
Approved |